Controversies in the pathogenesis of HIV-associated renal diseases

Nature Reviews Nephrology

Volumn 5, Issue 10, 2009, Pages 574-581

  Bruggeman, Leslie A ^a   Nelson, Peter J ^b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DEDIFFERENTIATION; CELL PROLIFERATION; DISEASE ASSOCIATION; GLOMERULUS EPITHELIUM; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY INJURY; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; REVIEW;

ANIMALS; DISEASE MODELS, ANIMAL; HIV INFECTIONS; HUMANS; KIDNEY DISEASES; MICE; PODOCYTES; RATS;

EID: 70349627550     PISSN: 17595061     EISSN: 1759507X     Source Type: Journal    
DOI: 10.1038/nrneph.2009.139     Document Type: Review

References (105)

1. Szczech, L. A. et al. The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection. Kidney Int. 66, 1145-1152 (2004).
2. Wyatt, C. M. et al. The spectrum of kidney disease in patients with AIDS in the era of antiretroviral therapy. Kidney Int. 75, 428-434 (2009).
3. Kiryluk, K., Martino, J. & Gharavi, A. G. Genetic susceptibility, HIV infection, and the kidney. Clin. J. Am. Soc. Nephrol. 2 (Suppl. 1), S25-S35 (2007).
4. Alpers, C. E. et al. Focal segmental glomerulosclerosis in primates infected with a simian immunodeficiency virus. AIDS Res. Hum. Retroviruses 13, 413-424 (1997).
5. Stephens, E. B., Tian, C., Li, Z., Narayan, O. & Gattone, V. H. 2nd. Rhesus macaques infected with macrophage-tropic simian immunodeficiency virus (SIVmacR71/17E) exhibit extensive focal segmental and global glomerulosclerosis. J. Virol. 72, 8820-8832 (1998).
6. Stephens, E. B., Tian, C., Dalton, S. B. & Gattone, V. H. 2nd. Simian-human immunodeficiency virus-associated nephropathy in macaques. AIDS Res. Hum. Retroviruses 16, 1295-1306 (2000).
7. Poli, A. et al. Renal involvement in feline immunodeficiency virus infection: a clinicopathological study. Nephron 64, 282-288 (1993).
8. Cohen, A. H. & Nast, C. C. HIV-associated nephropathy. A unique combined glomerular, tubular, and interstitial lesion. Mod. Pathol. 1, 87-97 (1988).
9. D'Agati, V., Suh, J. I., Carbone, L., Cheng, J. T. & Appel, G. Pathology of HIV-associated nephropathy: a detailed morphologic and comparative study. Kidney Int. 35, 1358-1370 (1989).
10. Strauss, J. et al. Renal disease in children with the acquired immunodeficiency syndrome. N. Engl. J. Med. 321, 625-630 (1989).
11. Ray, P. E., Xu, L., Rakusan, T. & Liu, X. H. A 20-year history of childhood HIV-associated nephropathy. Pediatr. Nephrol. 19, 1075-1092 (2004).
12. Wools-Kaloustian, K. K. & Gupta, S. K. Will there be an epidemic of HIV-related chronic kidney disease in sub-Saharan Africa? Too soon to tell. Kidney Int. 74, 845-847 (2008).
13. Kao, W. H. et al. MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Nat. Genet. 40, 1185-1192 (2008).
14. Kopp, J. B. et al. MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat. Genet. 40, 1175-1184 (2008).
15. Bruggeman, L. A. et al. Renal epithelium is a previously unrecognized site of HIV-1 infection. J. Am. Soc. Nephrol. 11, 2079-2087 (2000).
16. Cohen, A. H., Sun, N. C., Shapshak, P. & Imagawa, D. T. Demonstration of human immunodeficiency virus in renal epithelium in HIV-associated nephropathy. Mod. Pathol. 2, 125-128 (1989).
17. Kimmel, P. L., Ferreira-Centeno, A., Farkas-Szallasi, T., Abraham, A. A. & Garrett, C. T. Viral DNA in microdissected renal biopsy tissue from HIV infected patients with nephrotic syndrome. Kidney Int. 43, 1347-1352 (1993).
18. Eitner, F. et al. Chemokine receptor CCR5 and CXCR4 expression in HIV-associated kidney disease. J. Am. Soc. Nephrol. 11, 856-867 (2000).
19. Marras, D. et al. Replication and compartmentalization of HIV-1 in kidney epithelium of patients with HIV-associated nephropathy. Nat. Med. 8, 522-526 (2002).
20. Zerhouni-Layachi, B. et al. Dual tropism of HIV-1 envelopes derived from renal tubular epithelial cells of patients with HIV-associated nephropathy. AIDS 20, 621-624 (2006).
21. Eitner, F. et al. Chemokine receptor (CCR5) expression in human kidneys and in the HIV infected macaque. Kidney Int. 54, 1945-1954 (1998).
22. Gröne, H. J. et al. Spatial and temporally restricted expression of chemokines and chemokine receptors in the developing human kidney. J. Am. Soc. Nephrol. 13, 957-967 (2002).
23. Segerer, S., Mack, M., Regele, H., Kerjaschki, D. & Schlöndorff, D. Expression of the C-C chemokine receptor 5 in human kidney diseases. Kidney Int. 56, 52-64 (1999). (Pubitemid 29300521)
24. Gonzalez, E. et al. The influence of CCL3L1 genecontaining segmental duplications on HIV-1/ AIDS susceptibility. Science 307, 1434-1440 (2005).
25. Liu, X. H., Hadley, T. J., Xu, L., Peiper, S. C. & Ray, P. E. Up-regulation of Duffy antigen receptor expression in children with renal disease. Kidney Int. 55, 1491-1500 (1999).
26. Woolley, I. J. et al. HIV nephropathy and the Duffy antigen/receptor for Chemokines in African Americans. J. Nephrol. 14, 384-387 (2001).
27. He, W. et al. Duffy antigen receptor for chemokines mediates trans-infection of HIV-1 from red blood cells to target cells and affects HIV-AIDS susceptibility. Cell Host Microbe 4, 52-62 (2008).
28. Ray, P. E. et al. Infection of human primary renal epithelial cells with HIV-1 from children with HIVassociated nephropathy. Kidney Int. 53, 1217-1229 (1998).
29. Geijtenbeek, T. B. et al. DC-SIGN, a dendritic cellspecific HIV-1-binding protein that enhances trans-infection of T cells. Cell 100, 587-597 (2000).
30. Baribaud, F., Pöhlmann, S. & Doms, R. W. The role of DC-SIGN and DC-SIGNR in HIV and SIV attachment, infection, and transmission. Virology 286, 1-6 (2001).
31. Hatsukari, I. et al. DEC-205-mediated internalization of HIV-1 results in the establishment of silent infection in renal tubular cells. J. Am. Soc. Nephrol. 18, 780-787 (2007).
32. Mikulak, J., Teichberg, S., Faust, T., Schmidtmayerova, H. & Singhal, P. C. HIV-1 harboring renal tubular epithelial cell interaction with T cells results in T cell trans-infection. Virology 385, 105-114 (2009).
33. John, R. & Nelson, P. J. Dendritic cells in the kidney. J. Am. Soc. Nephrol. 18, 2628-2635 (2007).
34. Wu, L. & Kewalramani, V. N. Dendritic-cell interactions with HIV: infection and viral dissemination. Nat. Rev. Immunol. 6, 859-868 (2006).
35. Tanji, N. et al. Detection and localization of HIV-1 DNA in renal tissues by in situ polymerase chain reaction. Histol. Histopathol. 21, 393-401 (2006).
36. Conaldi, P. G. et al. HIV-persistent infection and cytokine induction in mesangial cells: a potential mechanism for HIV-associated glomerulosclerosis. AIDS 14, 2045-2047 (2000).
37. Tokizawa, S. et al. Infection of mesangial cells with HIV and SIV: identification of GPR1 as a coreceptor. Kidney Int. 58, 607-617 (2000).
38. Alpers, C. E., McClure, J. & Bursten, S. L. Human mesangial cells are resistant to productive infection by multiple strains of human immunodeficiency virus types 1 and 2. Am. J. Kidney Dis. 19, 126-130 (1992).
39. Green, D. F., Resnick, L. & Bourgoignie, J. J. HIV infects glomerular endothelial and mesangial but not epithelial cells in vitro. Kidney Int. 41, 956-960 (1992).
40. Kramer-Hämmerle, S., Rothenaigner, I., Wolff, H., Bell, J. E. & Brack-Werner, R. Cells of the central nervous system as targets and reservoirs of the human immunodeficiency virus. Virus Res. 111, 194-213 (2005).
41. Rosenstiel, P., Gharavi, A., D'Agati, V. D. & Klotman, P. Transgenic and infectious animal models of HIV-associated nephropathy. J. Am. Soc. Nephrol. doi:10.1681/ASN.2008121230
42. Bruggeman, L. A. et al. Nephropathy in human immunodeficiency virus-1 transgenic mice is due to renal transgene expression. J. Clin. Invest. 100, 84-92 (1997).
43. Dickie, P. et al. HIV-associated nephropathy in transgenic mice expressing HIV-1 genes. Virology 185, 109-119 (1991).
44. Kopp, J. B. et al. Progressive glomerulosclerosis and enhanced renal accumulation of basement membrane components in mice transgenic for human immunodeficiency virus type 1 genes. Proc. Natl Acad. Sci. USA 89, 1577-1581 (1992).
45. Zhong, J. et al. Expression of HIV-1 genes in podocytes alone can lead to the full spectrum of HIV-1-associated nephropathy. Kidney Int. 68, 1048-1060 (2005).
46. Hanna, Z. et al. Transgenic mice expressing human immunodeficiency virus type 1 in immune cells develop a severe AIDS-like disease. J. Virol. 72, 121-132 (1998).
47. Balog, K. & Minarovits, J. Nef: a pleiotropic modulator of primate lentivirus infectivity and pathogenesis. Acta Microbiol. Immunol. Hung. 53, 51-75 (2006).
48. Keppler, O. T. et al. Rodent cells support key functions of the human immunodeficiency virus type 1 pathogenicity factor Nef. J. Virol. 79, 1655-1665 (2005).
49. Hanna, Z. et al. Nef harbors a major determinant of pathogenicity for an AIDS-like disease induced by HIV-1 in transgenic mice. Cell 95, 163-175 (1998).
50. Priceputu, E. et al. Primary human immunodeficiency virus type 1 nef alleles show major differences in pathogenicity in transgenic mice. J. Virol. 81, 4677-4693 (2007).
51. Dickie, P. et al. Focal glomerulosclerosis in proviral and c-fms transgenic mice links Vpr expression to HIV-associated nephropathy. Virology 322, 69-81 (2004).
52. Kajiyama, W., Kopp, J. B., Marinos, N. J., Klotman, P. E. & Dickie, P. Glomerulosclerosis and viral gene expression in HIV-transgenic mice: role of nef. Kidney Int. 58, 1148-1159 (2000). (Pubitemid 30678038)
53. Husain, M., D'Agati, V. D., He, J. C., Klotman, M. E. & Klotman, P. E. HIV-1 Nef induces dedifferentiation of podocytes in vivo: a characteristic feature of HIVAN. AIDS 19, 1975-1980 (2005).
54. Zuo, Y. et al. HIV-1 genes vpr and nef synergistically damage podocytes, leading to glomerulosclerosis. J. Am. Soc. Nephrol. 17, 2832-2843 (2006).
55. Le, R. E. & Benichou, S. The Vpr protein from HIV-1: distinct roles along the viral life cycle. Retrovirology 2, 11 (2005).
56. Conaldi, P. G. et al. Human immunodeficiency virus-1 tat induces hyperproliferation and dysregulation of renal glomerular epithelial cells. Am. J. Pathol. 161, 53-61 (2002).
57. Doublier, S. et al. HIV-1 Tat reduces nephrin in human podocytes: a potential mechanism for enhanced glomerular permeability in HIVassociated nephropathy. AIDS 21, 423-432 (2007).
58. Fung, E. et al. Dissecting the role of HIV-Tat in HIVAN [abstract]. J. Am. Soc. Nephrol. 17, 64A (2006).
59. Wharram, B. L. et al. Podocyte depletion causes glomerulosclerosis: diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene. J. Am. Soc. Nephrol. 16, 2941-2952 (2005).
60. Faulhaber, J. R. & Nelson, P. J. Virus-induced cellular immune mechanisms of injury to the kidney. Clin. J. Am. Soc. Nephrol. 2 (Suppl. 1), S2-S5 (2007).
61. Lindemann, D. et al. Severe immunodeficiency associated with a human immunodeficiency virus 1 NEF/3'-long terminal repeat transgene. J. Exp. Med. 179, 797-807 (1994).
62. Reid, W. et al. An HIV-1 transgenic rat that develops HIV-related pathology and immunologic dysfunction. Proc. Natl Acad. Sci. USA 98, 9271-9276 (2001).
63. Reid, W. et al. HIV-1 transgenic rats develop T cell abnormalities. Virology 321, 111-119 (2004).
64. Santoro, T. J. et al. Growth failure and AIDS-like cachexia syndrome in HIV-1 transgenic mice. Virology 201, 147-151 (1994).
65. Skowronski, J., Parks, D. & Mariani, R. Altered T cell activation and development in transgenic mice expressing the HIV-1 nef gene. EMBO J. 12, 703-713 (1993).
66. Varin, A. et al. Synthetic Vpr protein activates activator protein-1, c-Jun N-terminal kinase, and NF-êB and stimulates HIV-1 transcription in promonocytic cells and primary macrophages. J. Biol. Chem. 280, 42557-42567 (2005).
67. Olivetta, E. et al. HIV-1 Nef induces the release of inflammatory factors from human monocyte/ macrophages: involvement of Nef endocytotic signals and NF-êB activation. J. Immunol. 170, 1716-1727 (2003).
68. Ensoli, B. et al. Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J. Virol. 67, 277-287 (1993).
69. Frankel, A. D. & Pabo, C. O. Cellular uptake of the tat protein from human immunodeficiency virus. Cell 55, 1189-1193 (1988).
70. Tobiume, M. et al. Extracellular Nef protein activates signal transduction pathway from Ras to mitogen-activated protein kinase cascades that leads to activation of human immunodeficiency virus from latency. AIDS Res. Hum. Retroviruses 18, 461-467 (2002).
71. Kapasi, A. A., Patel, G., Franki, N. & Singhal, P. C. HIV-1 gp120-induced tubular epithelial cell apoptosis is mediated through p38-MAPK phosphorylation. Mol. Med. 8, 676-685 (2002).
72. Singhal, P. C., Reddy, K., Franki, N. & Ding, G. HIV-1 gp120 envelope protein modulates proliferation of human glomerular epithelial cells. J. Cell. Biochem. 76, 61-70 (1999).
73. Singhal, P. C. et al. HIV-1 gp160 envelope protein modulates proliferation and apoptosis in mesangial cells. Nephron 76, 284-295 (1997).
74. Singhal, P. C., Sharma, P. & Garg, P. HIV-1 gp160 protein-macrophage interactions modulate mesangial cell proliferation and matrix synthesis. Am. J. Pathol. 147, 1780-1789 (1995).
75. Winston, J. A. et al. Nephropathy and establishment of a renal reservoir of HIV type 1 during primary infection. N. Engl. J. Med. 344, 1979-1984 (2001).
76. Douek, D. C., Roederer, M. & Koup, R. A. Emerging concepts in the immunopathogenesis of AIDS. Annu. Rev. Med. 60, 471-484 (2009).
77. Eustace, J. A. et al. Cohort study of the treatment of severe HIV-associated nephropathy with corticosteroids. Kidney Int. 58, 1253-1260 (2000).
78. Laradi, A., Mallet, A., Beaufils, H., Allouache, M. & Martinez, F. HIV-associated nephropathy: outcome and prognosis factors. Groupe d' Etudes Nephrologiques d'Ile de France. J. Am. Soc. Nephrol. 9, 2327-2335 (1998).
79. Cohen, S. D. & Kimmel, P. L. Immune complex renal disease and human immunodeficiency virus infection. Semin. Nephrol. 28, 535-544 (2008).
80. Vielhauer, V., Anders, H. J. & Schlöndorff, D. Chemokines and chemokine receptors as therapeutic targets in lupus nephritis. Semin. Nephrol. 27, 81-97 (2007).
81. Waldman, M., Marshall, V., Whitby, D. & Kopp, J. B. Viruses and kidney disease: beyond HIV. Semin. Nephrol. 28, 595-607 (2008).
82. Martinka, S. & Bruggeman, L. A. Persistent NF-êB activation in renal epithelial cells in mouse model of HIV-associated nephropathy. Am. J. Physiol. Renal Physiol. 290, F657-F665 (2005).
83. Ross, M. J., Martinka, S., D'Agati, V. D. & Bruggeman, L. A. NF-êB regulates Fas-mediated apoptosis in HIV-associated nephropathy. J. Am. Soc. Nephrol. 16, 2403-2411 (2005).
84. Ross, M. J. et al. HIV-1 infection initiates an inflammatory cascade in human renal tubular epithelial cells. J. Acquir. Immune Defic. Syndr. 42, 1-11 (2006).
85. O'Donnell, M. P. et al. Renal cell cytokine production stimulates HIV-1 expression in chronically HIV-1-infected monocytes. Kidney Int. 53, 593-597 (1998).
86. Heckmann, A. et al. IKK2 inhibitor alleviates kidney and wasting diseases in a murine model of human AIDS. Am. J. Pathol. 164, 1253-1262 (2004).
87. Albaqumi, M., Soos, T. J., Barisoni, L. & Nelson, P. J. Collapsing glomerulopathy. J. Am. Soc. Nephrol. 17, 2854-2863 (2006).
88. Ross, M. J., Bruggeman, L. A., Wilson, P. D. & Klotman, P. E. Microcyst formation and HIV-1 gene expression occur in multiple nephron segments in HIV-associated nephropathy. J. Am. Soc. Nephrol. 12, 2645-2651 (2001).
89. Barisoni, L., Kriz, W., Mundel, P. & D'Agati, V. The dysregulated podocyte phenotype: a novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV-associated nephropathy. J. Am. Soc. Nephrol. 10, 51-61 (1999).
90. Barisoni, L., Bruggeman, L. A., Mundel, P., D'Agati, V. D. & Klotman, P. E. HIV-1 induces renal epithelial dedifferentiation in a transgenic model of HIV-associated nephropathy. Kidney Int. 58, 173-181 (2000).
91. Nelson, P. J., Sunamoto, M., Husain, M. & Gelman, I. H. HIV-1 expression induces cyclin D1 expression and pRb phosphorylation in infected podocytes: cell-cycle mechanisms contributing to the proliferative phenotype in HIV-associated nephropathy. BMC Microbiol. 2, 26 (2002).
92. Dijkman, H., Smeets, B., van der Lack, J., Steenbergen, E. & Wetzels, J. The parietal epithelial cell is crucially involved in human idiopathic focal segmental glomerulosclerosis. Kidney Int. 68, 1562-1572 (2005).
93. Dijkman, H. B. et al. Proliferating cells in HIV and pamidronate- associated collapsing focal segmental glomerulosclerosis are parietal epithelial cells. Kidney Int. 70, 338-344 (2006).
94. Nagata, M. et al. Origin and phenotypic features of hyperplastic epithelial cells in collapsing glomerulopathy. Am. J. Kidney Dis. 32, 962-969 (1998).
95. Barisoni, L. & Nelson, P. J. Collapsing glomerulopathy: an inflammatory podocytopathy? Curr. Opin. Nephrol. Hypertens. 16, 192-195 (2007).
96. Appel, D. et al. Recruitment of podocytes from glomerular parietal epithelial cells. J. Am. Soc. Nephrol. 20, 333-343 (2009).
97. Ronconi, E. et al. Regeneration of glomerular podocytes by human renal progenitors. J. Am. Soc. Nephrol. 20, 322-332 (2009).
98. Thorner, P. S., Ho, M., Eremina, V., Sado, Y. & Quaggin, S. Podocytes contribute to the formation of glomerular crescents. J. Am. Soc. Nephrol. 19, 495-502 (2008).
99. Spektor, T. M. & Rice, J. C. Ring around the genes. Nat. Cell Biol. 9, 1343-1344 (2007).
100. Gherardi, D. et al. Reversal of collapsing glomerulopathy in mice with the cyclindependent kinase inhibitor CYC202. J. Am. Soc. Nephrol. 15, 1212-1222 (2004).
101. Nelson, P. J., Gelman, I. H. & Klotman, P. E. Suppression of HIV-1 expression by inhibitors of cyclin-dependent kinases promotes differentiation of infected podocytes. J. Am. Soc. Nephrol. 12, 2827-2831 (2001).
102. Nelson, P. J., D'Agati, V. D., Gries, J. M., Suarez, J. R. & Gelman, I. H. Amelioration of nephropathy in mice expressing HIV-1 genes by the cyclin-dependent kinase inhibitor flavopiridol. J. Antimicrob. Chemother. 51, 921-929 (2003).
103. He, J. C. et al. Retinoic acid inhibits HIV-1- induced podocyte proliferation through the cAMP pathway. J. Am. Soc. Nephrol. 18, 93-102 (2007).
104. Takano, Y. et al. Recovery and maintenance of nephrin expression in cultured podocytes and identification of HGF as a repressor of nephrin. Am. J. Physiol. Renal Physiol. 292, F1573-F1582 (2007).
105. Vaughan, M. R. et al. ATRA induces podocyte differentiation and alters nephrin and podocin expression in vitro and in vivo. Kidney Int. 68, 133-144 (2005).